HealthOrbit, Inc. - News Headlines

	Idenix Provides Update on HCV Clinical Development Activities (056-09.13.10)
	FDA Advisory Committee Recommends Approval of Forest Laboratories' Ceftaroline Fosamil for the Treatment of Community Acquired Bacterial Pneumonia and Complicated Skin and Skin Structure Infections (057-09.13.10)
	Santarus Licenses Novel Type 2 Diabetes Drug CYCLOSET (085-09.13.10)
	Genzyme Confirms Receipt of Unsolicited Proposal (014-09.06.10)
	Advanced Life Sciences' Journal Publication Highlights Powerful Chemistry Platform (021-09.06.10)
	Bionovo Receives Positive Guidance from FDA on Menerba® (059-09.06.10)
	Data from Mipomersen Phase 3 Trial in heFH Patients Presented at ESC (096-09.06.10)
	Results From Investigator-Sponsored Trials Presented at SSIEM Conference (097-09.06.10)
	New England Journal of Medicine Study Reports Xpert MTB/RIF a Faster, More Sensitive & Specific Test for Tuberculosis (TB) Than Current World Standards (137-09.06.10)
	Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro and Aspart With rHuPH20 in Type 1 and Type 2 Diabetes (138-09.06.10)